Accession Number: | 0001104659-21-024925 |
Date: | 2021-02-15 |
Issuer: | INTERCEPT PHARMACEUTICALS, INC. (ICPT) |
Original Submission Date: |
RICHARDSON LINDA M
C/O INTERCEPT PHARMACEUTICALS, INC.
10 HUDSON YARDS, FLOOR 37
NEW YORK, NY 10001
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-02-15 | A | 5,531 | a | $0.00 | 26,866 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
OPTION TO PURCHASE COMMON STOCK | 31.32 | 2021-02-15 | deemed execution date | A | 8,500 (a) | 2031-02-15 | common stock 8,500 | $31.32 | 8,500 | direct |
ID | footnote |
---|---|
f1 | represents restricted stock units granted to the reporting person. each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. the award shall be subject to a four-year vesting period, with the shares subject to the award vesting in four equal annual installments following the vesting commencement date. the vesting commencement date is february 15, 2021. |
f2 | the award shall be subject to a four-year vesting period, with 25% of the shares subject to the award vesting and becoming exercisable in an initial annual installment following the vesting commencement date and 1/48th of the shares subject to the award vesting and becoming exercisable each month thereafter. the vesting commencement date is february 15, 2021. |